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Abstract
Background: Mutations in Lipopolysaccharide-induced tumour necrosis factor-α factor (LITAF) cause the autosomal
dominant inherited peripheral neuropathy, Charcot-Marie-Tooth disease type 1C (CMT1C). LITAF encodes a 17 kDa
protein containing an N-terminal proline-rich region followed by an evolutionarily-conserved C-terminal ‘LITAF
domain’, which contains all reported CMT1C-associated pathogenic mutations.
Results: Here, we report the first structural characterisation of LITAF using biochemical, cell biological, biophysical and
NMR spectroscopic approaches. Our structural model demonstrates that LITAF is a monotopic zinc-binding membrane
protein that embeds into intracellular membranes via a predicted hydrophobic, in-plane, helical anchor located within
the LITAF domain. We show that specific residues within the LITAF domain interact with phosphoethanolamine (PE)
head groups, and that the introduction of the V144M CMT1C-associated pathogenic mutation leads to protein
aggregation in the presence of PE.
Conclusions: In addition to the structural characterisation of LITAF, these data lead us to propose that an aberrant
LITAF-PE interaction on the surface of intracellular membranes contributes to the molecular pathogenesis that
underlies this currently incurable disease.
Keywords: Lipopolysaccharide-induced tumour necrosis factor-α factor, Charcot-Marie-Tooth disease, Neuropathy,
Endosomes
Background
The Charcot-Marie-Tooth diseases (CMT) are among the
most common inherited neurological disorders, with an
estimated prevalence of 1 in 2500 [1]. CMT is associated
with progressive degeneration of peripheral nerves, lead-
ing to muscle wasting and weakness, sensory deficits and
limb deformities causing significant morbidity across
populations [2].
Peripheral nerves are composed of two main functional
anatomical structures: axons and Schwann cells. Axons
convey electrical signals to and from the central nervous
system and peripheries, while Schwann cells are neural
crest-derived cells that engulf peripheral axons providing
structural and trophic support. Furthermore, Schwann cells
can also be stimulated to wrap multiple layers of plasma
membrane around larger axons to form the insulating mye-
lin sheath, a process known as myelination. Consistent with
this anatomical and functional dichotomy, CMT can add-
itionally be classified into ‘axonal’ and ‘demyelinating’
forms, reflecting the main sites of cellular dysfunction as
the axon or Schwann cell, respectively [3].
With the advent of next-generation DNA sequencing,
mutations in more than 80 genes have now been shown to
be associated with CMT, highlighting key genes essential
for peripheral nerve function [4]. Of the genes associated
with demyelinating CMT, where Schwann cell dysfunction
is thought to be the primary underlying pathology, the
encoded proteins can be classified into three main groups:
structural proteins of the myelin sheath, transcription
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factors that activate the myelination programme and, inter-
estingly, proteins that are known or predicted to function
in intracellular membrane traffic [5]. While Schwann cell-
specific expression of CMT-associated proteins explains
particular subtypes of demyelinating CMT [6, 7], most
CMT-associated genes with known or predicted roles in
membrane traffic are widely expressed across diverse tis-
sues and species. Therefore, understanding why mutations
in these widely expressed genes lead to isolated demyelinat-
ing peripheral neuropathies requires further study at the
molecular level.
CMT type 1C (CMT1C) is an autosomal dominant de-
myelinating peripheral neuropathy associated with muta-
tions in LITAF (Lipopolysaccharide-induced tumour
necrosis factor-α factor) [8]. LITAF, which is also known
as SIMPLE, encodes a 17 kDa protein that targets endo-
cytic structures and contains an N-terminal proline-rich
region predicted to modulate protein-protein interac-
tions, and a C-terminal region predicted to encode a
‘LITAF domain’ (sometimes also referred to as a ‘SIM-
PLE-like domain’) consisting of conserved cysteine
residues separated by a 22 residue hydrophobic region
(Fig. 1) [9–15]. LITAF domains are conserved in
eukaryotes. Initial reports had proposed that LITAF
functions as a transcription factor [16]; however, a con-
sensus has now emerged that LITAF targets to
intracellular membranes and is therefore likely to play a
role in endocytic membrane trafficking [9–11, 13, 14, 17,
18]. Furthermore, LITAF has been shown to interact
with proteins involved in receptor trafficking and deg-
radation in tissue cell lines [9, 13, 19, 20]. Despite the
evolutionary conservation and widespread tissue
expression, no structural data currently exist concerning
the LITAF domain. On the contrary, conflicting models
regarding the topology and fold of this domain have
been proposed, without supporting experimental data
[11, 15, 17].
Here, we present the membrane topology, metal binding
and structural features of the human LITAF protein. The
biophysical and cell biological effects of the recruitment of
interacting proteins to LITAF are then reported, demon-
strating the importance of short peptide sequence motifs
in the N-terminal proline-rich region for LITAF’s intracel-
lular localisation. Finally, we show that distinct residues
contained within the LITAF domain interact with phos-
phoethanolamine (PE) head groups and that the alteration
of these interactions leads to protein aggregation in the
presence of a pathogenic CMT1C mutation, providing
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Fig. 1 The domain organisation of LITAF. Schematic diagram to illustrate the domain organisation of the LITAF protein. The N-terminus is characterised
by a proline-rich region which is followed by a LITAF domain at the C-terminus. The LITAF domain consists of two pairs of cysteine residues (indicated
with arrows and coloured red) either side of a hydrophobic region. The amino acid sequences of selected LITAF domains taken from a variety of
eukaryotes are shown to highlight the high degree of conservation of critical amino acid residues across species. Residues are numbered according to
the human LITAF sequence and coloured according to the Clustalx scheme as implemented in the Jalview program to highlight conserved amino acid
properties. Shading indicates the degree of conservation. The position of known CMT1C-associated pathogenic mutations are shown below
the alignment.
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molecular insights into the underlying pathogenesis of a
subtype of this currently incurable, common, inherited
disease.
Results
LITAF domains are evolutionarily conserved
LITAF domains are found throughout the eukaryotes,
suggesting ancient conserved functions (Additional file 1:
Figure S1), with multiple instances of expansion, espe-
cially in the metazoa. Of relevance to the current study,
one particular duplication appears to have occurred in the
common ancestor of the jawed vertebrates (gnathos-
tomes), leading to the eventual existence of two LITAF
domain-containing genes in humans: the so-far uncharac-
terised CDIP1 gene, and the CMT1C-associated gene,
LITAF (Additional file 2: Figure S2). Intriguingly, and des-
pite the large lineage-specific expansions seen in the
LITAF domain gene family as described, the canonical do-
main architecture – that is, a proline-rich domain at the
N-terminus followed by a C-terminal LITAF domain – is
conserved across eukaryotes (with the exception of the
apicomplexans), highlighting the likely requirement for
both regions to be present for correct intracellular protein
function (Additional file 3: Figure S3 and Additional file 4:
Figure S4a).
With the aim of identifying key conserved features that
are likely to be of critical functional importance, we gath-
ered a cohort of broadly representative LITAF domain se-
quences from which a comprehensive sequence alignment
was derived. This alignment revealed that two pairs of cys-
teines, located either side of a predicted hydrophobic helix
with amphipathic properties, are strictly conserved (Fig. 1
and Additional file 4: Figure S4b, c). These cysteine pairs,
in the absence of the intervening helix, are reminiscent of
metal-ion coordinating residues found in zinc-finger-like
structures [21]. Six additional cysteine residues are present
in the predicted hydrophobic helical region of the human
LITAF domain, but are less well conserved across our
alignment. As their sequence positions are not consistent
with the typical known cysteine-containing metal coordin-
ating motifs (e.g. CxxC/HxxC), it appears unlikely that
these additional cysteine residues are involved in coordin-
ating a metal ion.
Given that the luminal, transmembrane and cytosolic do-
mains of proteins are conserved to a different extent in evo-
lution [22, 23], the absolute conservation of these residues
in tandem led us to hypothesise that the N- and C-termini
of the LITAF domain are very unlikely to be separated by a
phospholipid bilayer-traversing transmembrane domain as
has been previously postulated [11]. Furthermore, most
CMT1C-associated pathogenic mutations fall at conserved
residues in this pan-eukaryotic alignment of LITAF do-
mains, again highlighting key residues likely to play critical
roles in maintaining the function of this ancient domain.
With these points in mind, we set out to re-examine
the role of the LITAF domain in targeting the protein to
membranes and to experimentally characterise the
topology of the human LITAF protein.
LITAF targets to membranes via the hydrophobic helical
region
The targeting of LITAF to membranes has previously been
shown to be via the C-terminal LITAF domain [11].
Consistent with previous reports, we found that LITAF
predominantly targeted endocytic vesicles, colocalising
with marker proteins of both early and late endosomes
(Additional file 5: Figure S5). This endosomal targeting and
association with membrane can be prevented by either de-
leting the predicted hydrophobic helical region within the
LITAF domain (HA-LITAF Δ114–139) or by mutating
eight hydrophobic residues contained therein (HA-
LITAF N-helix) (Fig. 2a–c). These eight hydrophobic
residues mutated in the N-helix construct are found on
one side of the predicted helix according to our helical
wheel analysis, consistent with an amphipathic charac-
ter (Additional file 4: Figure S4c, d). By mutating only
eight hydrophobic residues to arginine in generating the
N-helix construct, the predicted helical nature of this
region is preserved, leading us to hypothesise that, while
the protein is rendered more soluble, the overall folding
and architecture of the expressed molecule is main-
tained and remains similar to wild type. Endogenously
expressed LITAF also possesses the biochemical proper-
ties of an integral membrane protein, as shown by the
differential extraction of the protein with the detergent
TX114 (Fig. 2d). Thus, our data suggest that LITAF is
targeted and anchored to membranes via pivotal hydro-
phobic residues found within the predicted central
hydrophobic helical region of the C-terminal LITAF
domain.
Both the N- and C-termini of LITAF are found on the
cytosolic surfaces of vesicles
By analysing the sequences of LITAF domains from
Drosophila, Ponting et al. [15] first postulated that the pre-
dicted hydrophobic helical region probably inserted into,
but did not traverse, membranes. However, Lee et al. [11]
later assumed that this hydrophobic region within the
LITAF domain was a transmembrane helix, thereby con-
cluding that LITAF must be C-terminally inserted into
membranes. Importantly, neither hypothesis was supported
by experimental data. We therefore used two complemen-
tary experimental approaches to determine the membrane
topology of LITAF.
Firstly, we used a cellular semi-permeabilisation assay to
determine whether the N- and C-termini of LITAF were lo-
cated on the cytosolic or luminal membrane surfaces of
endosomes, respectively [24]. To do this, we generated
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HeLa cells stably expressing LITAF epitope-tagged with
HA on the N-terminus and myc on the C-terminus
(Fig. 3a). Following selective permeabilisation of plasma
membranes with 20 μM digitonin, both N-terminal HA
and C-terminal myc epitope tags were detected by indirect
immunofluorescence, concurrently with the cytosolic sur-
face endosomal marker protein VPS26. In contrast, the
LAMP1 epitope, found on the luminal side of endosomes
and lysosomes, was not detected, confirming the main-
tained integrity of endocytic compartment membranes
under these conditions (Fig. 3b, c). On the contrary, higher
concentrations of digitonin (100 μM) permeabilised both
plasma membranes and intracellular organelles/vesicles, ex-
posing epitopes found on both the cytosolic and luminal
surfaces of endosomes. These data are consistent with the
hypothesis that the hydrophobic region of the LITAF do-
main does not traverse membranes, meaning that both the
N- and C-termini face the cytosol.
Secondly, to verify our findings from the cellular semi-
permeabilisation assay, we used a rabbit reticulocyte lysate
cell-free system to express HA-LITAF-myc in the presence
of microsomes [25, 26]. Once incorporated into micro-
somal membranes, the susceptibility of both the N- and C-
terminal HA and myc epitope tags to protease digestion
was ascertained. Using the protection of the processed form
of β-lactamase within the microsomal lumen as control, we
observed that both the HA and myc tags of LITAF were de-
graded following incubation with proteinase K (Fig. 3d).
These data are therefore consistent with the semi-
permeabilisation assay, and are strongly supportive of the
hypothesis that both the N- and C- termini of LITAF are
found on the cytosolic surface of membranes, and that the
LITAF domain is embedded into membranes via the pre-
dicted hydrophobic helical region adopting an in-plane
membrane anchor configuration [27].
The LITAF domain coordinates zinc
With the two well-conserved cysteine-containing ‘knuckles’
either side of the hydrophobic helical anchor (Fig. 1 and
Additional file 4: Figure S4), reminiscent of intracellular
zinc-binding motifs [21], we next asked whether LITAF is
indeed a zinc-interacting protein. To address this question
unequivocally, we performed microPIXE (proton-induced
X-ray emission) analysis to determine the metal binding
characteristics of LITAF protein constructs expressed and
purified from E. coli. These experiments showed that wild
type LITAF, LITAF N-helix and LITAF Δ114–139 con-
tained 1.05 ± 0.21 [1.41, 1.05, 0.998], 1.55 ± 0.12 [1.42, 1.71,
1.51] and 0.90 ± 0.11 [0.86, 0.80, 1.05] zinc atoms/protein
molecule (mean ± SD, n = 3, different points collected from
the same sample of each protein), respectively (Fig. 4). Not-
ably, LITAF constructs where one or more of the conserved
cysteine residues had been replaced with alanine were all
insoluble when expressed in E. coli, and also appeared as
large puncta and could not be solubilised with TX100 when
transiently expressed in HeLa cells, consistent with them
being proteins prone to aggregation (Additional file 6:
Figure S6). When not playing a direct functional or catalytic
role, metal ions (most commonly zinc) often stabilise very
small protein domains, enabling them to interact with other
proteins or biomolecules [28]. These data therefore strongly
suggest that the correct folding of the LITAF domain is
dependent on the coordination of a zinc atom.
The LITAF domain consists of cysteine-containing β-hairpins
either side of the predicted hydrophobic helical anchor
We next set out to determine the structural characteris-
tics of LITAF. The first NMR experiments of wild type
LITAF in an extensive range of membrane-mimicking
detergent environments highlighted the crucial import-
ance of the correct choice of solubilising conditions.
Under all conditions tested, we observed no signals that
we would associate with a structured protein domain.
Based on the assumption that these structured residues
would be in close association with the membrane, and
the high tendency of these samples to form oligomers
and aggregate (Additional file 7: Figure S7), we refocused
on the LITAF Δ114–139 construct, where the hydropho-
bic anchor had been removed, thereby rendering this
construct soluble in the absence of detergents. 13C/15N-
labelled LITAF Δ114–139 protein was straightforwardly
expressed and purified from E. coli with an estimated
(See figure on previous page.)
Fig. 2 LITAF is anchored to membranes via hydrophobic residues contained within the LITAF domain. a Amino acid sequences of the hydrophobic
regions present in the protein constructs used to determine membrane insertion. Residues are numbered according to the full length human LITAF
sequence. Hydrophobic residues are coloured red, while acidic residues are coloured blue. Residues retained in all three constructs are indicated by
asterisks below the sequence. The grey box denotes the serine–glycine linker added in place of the predicted helix in the Δ114–139 construct. b The
HA-tagged LITAF constructs were transiently expressed in HeLa cells and the localisation determined by immunofluorescence microscopy. The endosomal
targeting of endogenously expressed VPS26 is shown in the left panels for comparison. The middle panels show that the endosomal membrane targeting
of LITAF is dependent on key hydrophobic residues within the hydrophobic region. Scale bar denotes 20 μm. c Membrane fractionation from HeLa cells
expressing endogenous LITAF and transiently expressed HA-tagged LITAF constructs. While both endogenous and HA-tagged wild type LITAF is found in
the membrane pellets (P), the LITAF constructs harbouring hydrophilic mutations (N-helix) and a deletion in the vicinity of the hydrophobic region (Δ114–
139) are found in the soluble fraction (S). Calnexin and tubulin were used as integral membrane and soluble protein controls, respectively. dWild type
LITAF displays the characteristics of an integral membrane protein as determined by the extraction of the endogenous protein from HeLa cells using
TX114. The integral membrane protein, Calnexin, and VPS26, which associates with, but does not insert into membranes, were used as controls
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Fig. 3 Membrane topology determination of LITAF. a Schematic diagram illustrating the LITAF protein tagged with HA at the N-terminus and myc at
the C-terminus used in the experiments to determine the membrane topology. b Selective permeabilisation of the plasma membranes of HeLa cells
stably expressing HA-LITAF-myc was achieved using 20 μM digitonin. Immunofluorescence microscopy was performed following incubation of the
digitonin-permeabilised cells with antibodies towards HA and myc in addition to the control proteins, VPS26 and LAMP1, located on the cytosolic and
luminal sides of endosomal membranes, respectively. The representative images show that both the N-terminal HA and C-terminal myc epitopes were
detected concurrently with VPS26, indicating that both termini of LITAF are located on the cytosolic surface of membranes. In contrast, LAMP1 was
not detected under these conditions. Permeabilsation of both plasma membrane and endosomal membranes was achieved at higher concentrations
of digitonin as seen in the lower panel. c Representative graphs of a selective permeabilisation experiment illustrating the proportion of cells staining
positive for HA (top panel) and myc (bottom panel) compared to VSP26 and LAMP1 (co-labelling and counting 400 cells) at increasing concentrations
of digitonin. Note that all cells staining positive for HA were also positive for myc and that even at 100 μM digitonin, not all cells stained positive for
LAMP1, indicating incomplete permeabilisation of endocytic vesicle membranes under these conditions. d HA-LITAF-myc was expressed using a rabbit
reticulocyte lysate expression system in the presence of microsomal membranes to allow membrane insertion. A protease protection assay was then
performed using proteinase K to determine the topology of the LITAF protein. In the presence of proteinase K, both N-terminal HA and C-terminal
myc tags were digested, indicating that these epitopes are present on the surface of microsomal membranes (bottom panel). β-lactamase, containing
a signal peptide that allows the translocation of a processed form to the interior of microsomal membranes, and hence protection from proteinase K
digestion, was used as a control (top panel)
Fig. 4 MicroPIXE analysis of LITAF Δ114–139. Top panels: Elemental maps (50 μm2) of the sulfur and zinc content of the LITAF Δ114–139 sample
obtained from the proton induced X-ray emission (PIXE). The protein dries to the outside of the drop, giving an arc of sulfur which correlates with
the zinc signal. The positions for the three-point spectra collected are marked. Bottom panel: X-ray energy spectrum for one of the points,
showing the sulfur and zinc in the protein and the bromine from the buffer. Note the logarithmic scale on the y-axis
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molecular weight of 17 kDa, as determined using a 1D
proton transverse relaxation experiment, consistent with
a monomeric species in solution.
Initially, we performed standard NMR triple resonance
backbone experiments to assign and analyse the individual
amino acid residues within the LITAF Δ114–139 protein.
The BEST-TROSY experiments focus on the backbone
NH bonds of the protein, with each cross peak displayed
corresponding to a specific assigned amino acid (Fig. 5).
As mentioned above, the N-terminal region of LITAF con-
tains multiple proline residues (which lack a backbone
NH bond), and therefore the assignment of these amino
acids also required the use of supplementary experiments
(as outlined in Methods). Using these approaches, and
despite missing assignments for the glycine-serine linker
that replaces the hydrophobic region in the LITAF Δ114–
139 construct, an 89% assignment (including the assign-
ment of 20 out of 23 proline residues) was achieved.
Unsurprisingly, the LITAF N-helix construct also
remained soluble in the absence of detergent. However,
similarly to wild type LITAF, the assignment experi-
ments on this construct were also unsuccessful, likely
due to the tendency for the N-helix construct to form
higher molecular weight oligomers (Additional file 7:
Figure S7). Nevertheless, considerable overlap was evi-
dent between the N-helix and Δ114–139 constructs in
the BEST-TROSY experiments (Additional file 8: Figure
S8), suggesting that both LITAF constructs contain very
similar secondary structure elements, implying that fur-
ther interpretation of the Δ114–139 construct would en-
able key structural motifs of the wild type LITAF protein
to be defined.
Building on the near complete assignment of the pro-
tein, we proceeded to determine which secondary struc-
tural elements are present in the LITAF Δ114–139
construct. This particular approach exploits the exquisite
Fig. 5 Assignment of the 15N BEST-TROSY of the LITAF Δ114–139 construct. Cross-peaks assigned to the structured LITAF domain have a wide
proton distribution (~7.5 to 9.6 ppm) consistent with the secondary structure of β-strands. In contrast, cross-peaks assigned to the unstructured
N-terminal proline-rich arm occupy the narrower random coil central region of the spectrum (7.8 to 8.4 ppm)
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sensitivity of the backbone amino acid chemical shifts to
their related secondary structure environment. By using
the chemical shift analysis program, TALOS+ [29], we
established that the LITAF domain of the Δ114–139
construct is composed of 5 β-strands: 3 N-terminally to
the Δ114–139 deletion site (where the predicted hydro-
phobic helix would usually reside) and two forming a β-
hairpin at the C terminus (Additional file 9: Figure S9a).
Supporting these data, the residues assigned to the
LITAF domain displayed greater 1H chemical shift distri-
butions (~7.4 to 9.6 ppm), typical of β-sheet residues
(Fig. 5), compared to the residues assigned to the N-
terminal proline-rich region, which, in contrast, dis-
played a narrower 1H chemical shift pattern (between
7.8 and 8.4 ppm), suggesting the adoption of a random
coil character.
The dynamic qualities of the LITAF Δ114–139 con-
struct were next analysed by performing heteronuclear
NOE (hetNOE) experiments. These experiments meas-
ure the motion of each assigned residue on a picosecond
time scale. Positive hetNOE values close to the value of
1.0 represent slow picosecond motion, which is typically
seen when protein domains adopt rigid secondary struc-
ture motifs, while small, or even negative, hetNOE
values result from fast picosecond motion as seen in un-
structured loops and at the flexible termini of proteins.
The hetNOE analysis of the Δ114–139 construct, illus-
trated in (Additional file 9: Figure S9b), demonstrated
that four of the five β-strands within the LITAF domain
are rigid in the picosecond time scale, while in compari-
son, the first, most N-terminal β-strand, showed in-
creased motion, and hence flexibility. In contrast, the
proline-rich N-terminus showed mainly fast picosecond
motion reminiscent of an unstructured protein domain.
Interestingly, these analyses also revealed an area of re-
duced flexibility between residues 22 and 34, a region
known to recruit interacting proteins to the LITAF
molecule (Additional file 4: Figure S4a) [13].
NMR-based structural model
In order to further characterise the structure of the LITAF
domain, nuclear Overhauser effect spectroscopy (NOESY)
spectral data were collected. These experiments probe the
proximity of amino acids through space, thereby providing
indicative data concerning the tertiary structure of the pro-
tein. We used Rosetta, the protein structure prediction suite
of programs, to produce a structural model of the LITAF
domain as only a limited number of NOESY cross-peaks
were collected. Although Rosetta can be used in its most
basic form to predict a protein structure based only on its
primary sequence [30], more advanced Rosetta applications
allow additional restraint information to be applied during
the model calculations, making it possible to build a struc-
tural model that satisfies all our experimental data,
including metal coordination, secondary structure boundar-
ies, topology and NOE restraints [31]. After fragment selec-
tion for the model calculation, completed using Rosetta-CS
and the NMR-defined secondary structure boundaries,
Rosetta metalloprotein relax protocols were implemented
as previously described [32], where the four conserved cyst-
eine residues fixed for zinc coordination were C96, C99,
C148 and C151 (full length residue numbering). A total of
5000 decoys for each of the two sequences, wild type and
the Δ114–139 construct, were calculated and the quality of
the models analysed by clustering using Calibur [33].
Figure 6 shows the structural models of the LITAF Δ114–
139 and full-length LITAF domains, representing the
largest clusters of similar structures.
The NMR-based model of the LITAF Δ114–139 con-
struct (Fig. 6a), generated from the experimentally deter-
mined restraints, illustrate the five β-strands of the LITAF
domain: three in an antiparallel orientation at the N-
terminus and a β-hairpin at the C-terminus. The con-
served cysteine residues, which reside within loops located
between β-strands 2 and 3, and between β-strands 4 and
5, are shown to coordinate a zinc atom. Although the five
β-strands do not form a continuous sheet, they are in
close proximity and are part of an overall compact do-
main. The glycine/serine linker, that has replaced the pre-
dicted hydrophobic in-plane membrane anchor in the
LITAF Δ114–139 construct, has been modelled as a short
helix by Rosetta. The secondary structure elements are
again maintained in the wild type model of the LITAF do-
main (Fig. 6b), with the predicted hydrophobic in-plane
membrane anchor modelled as a single helix by Rosetta.
As the coordination of the zinc atom has been maintained,
this structure is not as compact as the LITAF Δ114–139
construct, and results in the β-strands lying parallel to the
predicted membrane-anchoring helix. The critical coord-
ination of the zinc atom by two pairs of cysteine residues,
as shown in both models, is consistent with the rubre-
doxin, or ‘zinc β-ribbon’ family of zinc finger structural
motifs [21]. Efforts to crystallize the LITAF constructs for
further structural analysis were unsuccessful.
Recruitment of proteins to the N-terminal proline-rich
region directs LITAF to specific endosomal structures
Specific protein domains are known to interact with par-
ticular sequence motifs present in the LITAF N-terminal
proline-rich region (Additional file 4: Figure S4a). Thus, the
PPXY motif can bind the WW domains of the ubiquitin
ligase, NEDD4 (Fig. 7a) [34], while the overlapping P(S/
T)AP motif is predicted to interact with the UEV domain
of the ESCRT-I component, TSG101 [35]. Our hetNOE
data suggest that the N-terminal region of LITAF is mostly
flexible, in contrast to the relatively rigid C-terminal
membrane-anchoring LITAF domain. We next asked what
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effect the recruitment of proteins to the N-terminal
proline-rich region has on the LITAF protein.
Based on the near complete (89%) assignment of the
LITAF Δ114–139 construct, we probed the local inter-
action of LITAF with the WW domains of NEDD4. A
comparison of the BEST-TROSY spectra of the 15N-la-
belled LITAF Δ114–139 in the presence and absence of
recombinantly-expressed NEDD4 596–944 (containing
the four WW domains) revealed the loss of a subset of
amide cross peaks (Fig. 7b), most often caused by line
broadening as a result of micromolar binding affinities.
The missing signals correspond to residues 22–29 of the
LITAF protein, which contain the PPSY motif known to
interact with the WW domains of NEDD4, and are within
a region of the N-terminal domain found to be less flex-
ible in the hetNOE experiments. Of note, a second region
between residues 57 and 72 of LITAF, which contains a
second PPSY motif, showed peak broadening representing
a potential additional NEDD4-WW domain interacting
site. However, the functional significance of this second
PPSY motif is uncertain, since it could not compensate for
the loss of the first N-terminal PPSY motif in our pull-
down experiments of endogenous NEDD4 from cellular
lysates (Fig. 7a). Significantly, we did not detect any conse-
quent structural changes to the C-terminal LITAF domain
upon binding of NEDD4 to the N-terminal proline-rich
region, showing that these regions of LITAF are structur-
ally independent.
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Fig. 6 Rosetta structural models of LITAF. a Rosetta model of the C-terminal LITAF domain region of the LITAF Δ114–139 construct. The residue
numbers correspond to the wild type human sequence. The zinc-coordinating cysteine residues are coloured yellow and the zinc atoms are
illustrated by purple balls. b Rosetta model of the wild-type C-terminal LITAF domain. The zinc-coordinating cysteine residues are coloured yellow
and the zinc atoms are illustrated by purple balls. The models calculated satisfy the known structural data: zinc coordination, NOE restraints and
β-strand boundaries, with both models adopting a rubredoxin or zinc ribbon fold
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With no apparent structural effect on the C-terminal
LITAF domain, we next asked whether the intracellular
localisation of LITAF is influenced by the potential
recruitment of proteins in vivo. HA-tagged LITAF
constructs harbouring mutations that disrupt the PPSY
motifs (Y23,61A) were expressed in retinal pigmented
epithelial cells (where no endogenously expressed LITAF
can be detected) and analysed by immunofluorescence
Fig. 7 Recruitment of proteins to the proline-rich region determines the intracellular targeting of LITAF. a The first PPSY motif of LITAF (residues 20–23)
interacts with the ubiquiting ligase, NEDD4. GST-LITAF 1–77 constructs (corresponding to the N-terminal proline-rich region), were recombinantly expressed
and purified from E. coli, before incubation with cellular lysates prepared from retinal pigment epithelial (RPE) cells. A pull-down experiment was performed
and the interacting proteins were separated by SDS-PAGE followed by western blotting. b The chemical shift perturbations seen in the LITAF Δ114–139
construct following incubation with recombinantly expressed NEDD4 596–944 (containing the 4 WW domains). A number of peaks are line-broadened
indicating the interaction of the NEDD4 WW domains with these discrete regions of the LITAF proline-rich N-terminus. The interaction of NEDD4 with the
proline-rich region had no effect on the C-terminal LITAF domain. c Representative images of confocal immunofluorescence microscopy of RPE cells stably
expressing HA-LITAF wild type (WT) and HA-LITAF Y23A/Y61A. While HA-LITAF WT predominantly targets to endocytic vesicles, HA-LITAF Y23A/Y61A is
mislocalised to the plasma membrane, labelled with wheat germ agglutinin (WGA). The merged images contain WGA coloured green and HA-LITAF
coloured purple with areas of colocalisation appearing white. Scale bars denote 10 μm. d The colocalisation of HA-LITAF constructs with WGA was
quantified using Volocity (Perkin Elmer) and a Pearson’s Correlation calculated; 10–13 images (each containing between four and five cells per field of
vision) were taken from three biological replicates per cell line stably expressing the LITAF constructs. The Pearson’s correlation was calculated by the
Volocity software with the threshold applied as previously described [87] (see Additional file 14 for individual data values). The graph shows the mean
values with error bars denoting SEM. A P value of 0.01 was calculated using an unpaired two-tailed t-test. Significantly greater amounts of the HA-LITAF
Y23,61A protein colocalised with WGA compared to wild type, confirming mislocalisation of the mutated construct towards the plasma membrane
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microscopy (Fig. 7c). We found that disruption of the
PPSY motifs led to significantly greater colocalisation of
LITAF with the plasma membrane marker, wheat germ
agglutinin, compared to the wild type protein (Fig. 7d).
These data lead us to speculate that, while LITAF
domains function as membrane anchors, the specific
intracellular localisation is potentially influenced by the
recruitment of interacting proteins to the relatively
flexible and cytosol-facing N-terminal poly-proline arm.
LITAF interacts specifically with PE head groups
As a zinc-binding structure anchored to the surface of
membranes, distinct residues within the LITAF domain
would be predicted to be in close proximity to phospholipid
head groups. We therefore asked whether particular
residues contained within the LITAF domain are able to
interact with phospholipid head groups in solution. To this
end, 15N-labelled LITAF Δ114–139 was incubated with
phosphoglycerol (PG), phosphocholine (PC), PE, phospho-
serine (PS) and the polyphosphatidylinositol head group
mimic, inositolhexakisphosphate (IP6) [36–39], and ana-
lysed by NMR in molar ratios up to 1:1000 protein:head
group (Additional file 10: Figure S10). While no interaction
was seen between LITAF and PG, PC, PS or IP6, we identi-
fied discrete interactions between specific residues located
in the C-terminal LITAF domain and PE head groups. As
expected from the structural model, these PE-interacting
residues reside within regions of the LITAF domain that
would be predicted to be in close proximity with the sur-
face of membranes (Fig. 8a and Additional file 11: Figure
S11a), lending further support to the validity of our model.
The V144M CMT1C-associated mutation leads to subtle
changes in the LITAF Δ114–139 construct and disrupts
the interaction with PE
All known CMT1C-associated pathogenic mutations in
LITAF are found in the C-terminal LITAF domain. Most
mutations reside within the predicted hydrophobic anchor
region and are predicted to disrupt the helical propensity
of this specific part of the protein (Fig. 1 and Additional
file 12: Figure S12a) [40–42]. However, as stated above, ex-
perimental study by NMR spectroscopy of constructs con-
taining the predicted hydrophobic helical region were not
possible. Nevertheless, the LITAF Δ114–139 construct
used to generate the structural model does contain valine
at position 144, a residue that, when mutated to a methio-
nine (V144M), is known to cause CMT1C [43]. The
V144M mutation does not affect membrane association
and its punctate staining pattern by immunofluorescence
microscopy is consistent with retained endosomal target-
ing (Additional file 12: Figure S12b, c). We therefore set
out to characterise the effects of this pathogenic mutation
by solution NMR spectroscopy. Additional file 11: Figure
S11b shows the chemical shift perturbations that are
manifested by the V144M mutation in the Δ114–139 con-
struct when compared to the wild type counterpart. If the
amino acid substitution had little effect on the construct,
we would expect that only signals corresponding to resi-
dues in close proximity to the site of mutation would be
perturbed. However, dispersed chemical shift perturba-
tions were seen as a result of this CMT1C mutation, in-
cluding within the region of the N-terminal β-sheets on
the opposite side of the deleted hydrophobic anchor.
These data therefore suggest that the V144M pathogenic
mutation causes subtle biochemical and biophysical
changes whilst maintaining the overall secondary struc-
ture of the LITAF domain, pointing towards an additional
factor that must lead to clinical disease.
By analysing the residues that show the greatest chem-
ical shift perturbations following the introduction of the
V144M mutation, we noted that these residues corres-
pond to those that interact with PE head groups (Fig. 8a,
b and Additional file 11: Figure S11b). We therefore
asked whether the interaction of the LITAF domain with
PE is altered by the introduction of the V144M muta-
tion. Indeed, we found that LITAF Δ114–139 V144M in-
teracts with PE at lower head group concentrations
(1:250 molar ratio) than the wild type construct whilst
utilising the same specific residues (Additional file 13:
Figure S13). However, while the V144M construct –
similarly to the LITAF Δ114–139 WT protein –
remained soluble and un-degraded for periods of many
months when stored in isolation, this mutant construct
became rapidly insoluble when incubated with PE at
1:1000 molar ratio, leading to the disappearance of the
assigned peaks from the NMR spectra and visible pre-
cipitation (Fig. 8c and Additional file 13: Figure S13). In
contrast, wild type LITAF Δ114–139 remained consist-
ently soluble and folded at these concentrations of PE.
To determine the effect of the V144M mutation on the
stability of LITAF in vivo, we performed cycloheximide
chase experiments in retinal pigment epithelial (RPE)
cells stably expressing either wild type HA-LITAF or
HA-LITAF V144M. In keeping with our in vitro find-
ings, HA-LITAF harbouring the V144M mutation was
degraded more rapidly compared to the wild type con-
struct (Fig. 8d). These data therefore suggest that the
V144M pathogenic mutation alters the interaction be-
tween the LITAF domain and PE head groups, pointing
towards an acquired misfolded state on the surface of
membranes, and potentially deleterious effects on intra-
cellular membranes involved in endocytic traffic.
Discussion
Despite the extensive architectural conservation of LITAF
domains across eukaryotes, our report is the first to char-
acterise this ancient domain structurally. In contrast to
the assertion made by Lee et al. [11] that LITAF domains
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are C-terminally inserted into membranes, our data show
that the hydrophobic region does not traverse membranes,
demonstrating that both the N-terminal and C-terminal
halves of the LITAF domain reside on the cytosolic sur-
face of membranes, in agreement with an earlier proposal
made by Ponting et al. [15] in 2002 and the recent publi-
cation by Qin et al. [44]. The LITAF domain consists of
five β-sheets, three N-terminal and two C-terminal to the
predicted hydrophobic anchor region, and is stabilised by
the coordination of a zinc atom by two pairs of
evolutionarily-conserved cysteine residues. In contrast, the
N-terminal proline-rich region is mostly unstructured and
behaves independently of the C-terminal LITAF domain.
We show that, far from being an inert component of the
full length protein, the ability of the proline-rich region to
bind to other cytosolic proteins appears to have a signifi-
cant influence on intracellular targeting. These data there-
fore support the notion that, while LITAF domains serve
as intracellular membrane anchors, the precise function
and localisation is determined by the proteins that interact
with the proline-rich N-terminal arm. This last point
might help explain the many contradictory data that cur-
rently exist concerning the specific intracellular localisa-
tion of LITAF-domain-containing proteins in a variety of
cell types [9–11, 13, 18].
Consistent with a protein domain that resides in close
proximity to membranes, we also show that specific resi-
dues within the LITAF domain interact with PE head
groups. PE is the second most abundant phospholipid
(behind PC) in mammalian cells, accounting for, on
average, approximately 25% of cellular phospholipids. PE
is found across all intracellular membranes and, as a
consequence of its cone-shape, has been proposed to
play an essential role in membrane fusion and curvature
[45]. By accommodating and interacting with PE head
groups, it is tempting to speculate that LITAF domains
might therefore play further roles in the regulation of
membrane invagination and tubulation, which are essen-
tial for the sorting and recycling of membranous cargoes
on endosomes [46].
Our data are consistent with LITAF being a monoto-
pic membrane protein anchored to membranes via an
in-plane helical membrane anchor, present within the
LITAF domain [27]. However, efforts to analyse the full
length LITAF protein, or the predicted hydrophobic hel-
ical anchor region in isolation, either by solution NMR
or crystallography, were unsuccessful, likely due to the
inability of the tested detergent and lipid micelles to
mimic the membrane environment found intracellularly.
Furthermore, the molecular weight of LITAF remains
too small for current cryo-EM techniques [47]. This
again highlights the general issue in structural biology
that, despite the fact that membrane proteins make up
approximately 30% of all eukaryotic cellular proteins
[48] and constitute around 60% of current drug targets
[49], membrane proteins still account for less than 1% of
structures in the Protein Data Bank [50]. Moreover,
none of these current membrane protein structures con-
tained within the database demonstrate in-plane mem-
brane anchoring domains as we propose for LITAF. In
the absence of a predicted helix-loop-helix ‘hairpin’
motif that inserts into the lipid bilayer as postulated for
other integral membrane proteins [51], we can therefore
only speculate at present on how precisely the predicted
hydrophobic helical anchor associates with membranes.
However, our data regarding the loss of membrane asso-
ciation following the substitution of eight hydrophobic
amino acids within the predicted helix, in conjunction
with our structural data, lead us to speculate that this
anchoring-region embeds into the cytosolic-facing
monolayer of the membrane bilayer by adopting an
amphipathic character [52, 53].
Schwann cells are predicted to be the principal site of
pathology in the demyelinating subtypes of CMT. Due
to the significant number of genes associated with de-
myelinating CMT that are predicted or known to encode
proteins that function on endocytic pathways [5], the
critical importance of intracellular membrane trafficking
in maintaining peripheral nerve myelination by Schwann
cells has been brought to the fore. Most mutations in
(See figure on previous page.)
Fig. 8 LITAF interacts with PE head groups and leads to protein instability in the V144M CMT1C-associated protein construct. a The position of residues
displaying chemical shift perturbations greater than 1 standard deviation of the mean observed in the presence of PE head groups are coloured orange
on the structural model of the LITAF domain. The illustration also shows the possible orientation of the LITAF domain as it inserts into a membrane
containing phosphotidylethanolamine and phosphatidylcholine [85]. A cartoon diagram of the topology of the LITAF protein embedded in a lipid
membrane bilayer (green), additionally showing the position of the flexible N-terminal proline-rich region (red), is shown in the inset. b The location of the
residues displaying chemical shift perturbations greater than 1 standard deviation from the mean following the introduction of the V144M mutation are
shown in blue on the structural models of the LITAF domain (LITAF Δ114–139 on the left and LITAF WT on the right). The position of Valine 144 is shown
in red. c Equal amounts of LITAF Δ114–139 were incubated with increasing concentrations of PE for 2 hours at room temperature before centrifugation at
20,000 × g for 10 minutes to obtain soluble (S) and insoluble (P) fractions, respectively. The fractions were then separated by SDS-PAGE prior to staining
with Coomassie Blue. In contrast to the WT construct (left panel), the V144M mutation rendered the protein unstable in the presence of
higher concentrations of PE, leading to precipitation (right panel). d Retinal pigment epithelial cells stably expressing either HA-LITAF WT
or HA-LITAF V144M were incubated with 300 μg/mL cycloheximide and incubated at 37 °C for the times indicated. Cellular lysates were
prepared and the amount of HA-LITAF protein was determined by western blotting
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these demyelinating CMT genes associated with mem-
brane trafficking cause disease in an autosomal recessive
manner, pointing towards loss of cellular function as the
underlying pathogenic mechanism in these instances. In
contrast, CMT1C associated with mutations in LITAF is
inherited in an autosomal dominant pattern. Previous
reports have confirmed that the expression of LITAF is
not critical for peripheral nerve myelination in mice
[54], making the ‘dominant-negative’ hypothesis, due to
the possible formation of non-functional LITAF hetero-
oligomers (containing wild type and mutant species), less
likely. On the contrary, a more probable pathogenic
mechanism involves a ‘toxic gain-of-function’ resulting
from the altered molecular and cellular properties of
mutant LITAF when expressed in vivo [55]. Significantly,
the LITAF protein is known to be widely expressed
across tissues [11], suggesting that, while compensatory
mechanisms must exist in most cell types, the intracellu-
lar membrane trafficking pathways in Schwann cells
must be distinctly susceptible to the presence of a mu-
tant copy of LITAF.
But how do CMT1C point mutations cause toxicity?
Thus far, all proven CMT1C-associated pathogenic
mutations in LITAF are found in the C-terminal LITAF
domain and previous reports have suggested that these
mutations might disrupt the association of LITAF with
membranes [11], although the precise mechanism
remained unclear. Here, we show that the CMT1C-
associated pathogenic V144M mutation in LITAF leads
to chemical shift perturbations across the LITAF domain
that sits in close approximation to the surface of
membranes, whilst maintaining an overall secondary
structure similar to the wild type protein. However,
when the V144M construct was incubated with PE head
groups, the disease-associated protein became misfolded,
leading to precipitation in vitro, in complete contrast to
wild type LITAF. Furthermore, cycloheximide chase ex-
periments in vivo suggested that the V144M construct
was degraded more rapidly compared to wild type. It is
therefore tempting to speculate that all CMT1C muta-
tions might lead to similar structural alterations within
the LITAF domain, resulting in an unstable and toxic
interaction with lipid head groups and consequent endo-
cytic membrane disruption [10, 56]. This aberrant
association of LITAF with membranes might lead to the
dysfunctional trafficking of Schwann cell membrane re-
ceptors, including growth factor receptors [9, 57, 58]
and cell adhesion molecules [6, 59], with consequent dis-
ruption of the critical endocytic pathways that maintain
the integrity of peripheral nerve myelin. Such mistraf-
ficking would, in turn, lead to instability of the myelin
sheath, demyelination, secondary axonal degeneration
and, eventually, the motor and sensory deficits that
characterise patients affected by a diagnosis of CMT1C.
Conclusions
In summary, we present the first structural protein
model of LITAF based on experimental data, and de-
scribe the biophysical and biochemical consequences of
a CMT1C-associated pathogenic mutation. We antici-
pate that this work will form a platform for the future
study of LITAF, and LITAF-domains in general, and
their role in intracellular membrane trafficking. In the
absence of any current treatments for CMT, we believe
that such investigation will not only lead to the identifi-
cation of future therapeutic strategies for CMT1C, but
will also highlight molecular and cellular dysfunctional
pathways common to more than one subtype of this
common, currently incurable, neurological disorder.
Methods
Reagents and cell culture
Antibodies and reagents used during this study include
mouse anti-LITAF (BD Biosciences, #611614, RRID:
AB_399056, Lot #29025), rabbit anti-VPS26 (gift from M.
N. J. Seaman, Cambridge UK), mouse anti-LAMP1 (DSHB,
H4A3, RRID: AB_2296838), mouse anti-EEA1 (BD Biosci-
ences, #610457, RRID: AB_397830, Lot #5023919), rabbit
anti-TGN46 (Abcam, ab50595, RRID: AB_2203289, Lot
#GR133666-6), mouse anti-HA (16B12, Covance, mms-
101R-50), anti-myc (9B11, Cell Signaling, #2276S, RRID:
AB_10693333, Lot #19), rabbit anti-Flag (Cell Signaling,
#2368, RRID: AB_2217020, Lot #6), rabbit anti-calnexin
(Santa Cruz, sc-11397, RRID: AB_2243890, Lot #F1808),
rabbit anti-NEDD4 (Abcam, ab14592, RRID: AB_301364),
mouse anti-GAPDH (Sigma, G8795, RRID: AB_1078991,
Lot #092M4820V), mouse anti-β-lactamase (Abcam,
ab12251, RRID: AB_298974), mouse anti-α-tubulin (DSHB,
AA4.3, RRID: AB_579793, Lot #8/29/13), rabbit anti-GFP
(Thermo Fisher Scientific, A11122, RRID: AB_10073917,
Lot #1453341), CF488A Wheat Germ Agglutinin (Biotium,
#29022-1, Lot #15 W0225), Alexa Fluor 488- (Thermo
Fisher Scientific, A11034, RRID: AB_2576217, Lot
#939304), Alexa Fluor 568-conjugated goat anti-rabbit H +
L (Thermo Fisher Scientific, A11036, RRID: AB_10563566,
Lot # 757102), goat anti-mouse H+ L (Thermo Fisher Sci-
entific, A11031, RRID: AB_144696, Lot #1126619), Alexa
Fluor 488-conjugated goat anti mouse IgG1 (Thermo Fisher
Scientific, A21121, RRID: AB_2535764, Lot #1485220), and
Alexa-Fluor 555-conjugated anti-mouse IgG2a (Thermo
Fisher Scientific, A21137, RRID: AB_2535776, Lot #
1541489). HRP-conjugated goat anti-rabbit and goat anti-
mouse antibodies were used as secondary antibodies for
western blotting (Sigma-Aldrich). Proteins separated by
SDS-PAGE followed by transfer to nitrocellulose mem-
branes were detected using WesternBright ECL western
blotting detection kit (Advansta, CA, USA).
Full length cDNAs for LITAF (IMAGE clone 4000250)
and NEDD4 (IMAGE clone 8860509) were obtained
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from Source Bioscience (Cambridge, UK). LITAF Δ114–
139 and LITAF N-helix constructs were generated using
synthesized gBlocks (Integrated DNA Technologies,
Iowa, USA) and Gibson cloning into the relevant expres-
sion vectors (NEB) [60]. Site-directed mutagenesis was
performed using a QuikChange II XL kit (Stratagene).
All DNA constructs were sequenced and validated by
Source Bioscience (Cambridge, UK).
HeLa cells (gift from F. Buss, Cambridge UK) were
grown at 37 °C in RPMI (Sigma-Aldrich) containing 10%
FCS and 2 mM L-glutamine, 100 U/mL penicillin and
100 μg/mL streptomycin in a 5% CO2 humidified atmos-
phere. RPE cells (ARPE-19, ATCC) were grown at 37 °C
in DMEM:Ham’s F-12 (50:50) (Sigma-Aldrich) containing
10% FCS and 2 mM L-glutamine, 100 U/mL penicillin
and 100 μg/mL streptomycin in a 5% CO2 humidified at-
mosphere. Cells were transfected using polyethylenimine
(Polysciences, PA, USA) or Lipofectamine LTX (Thermo
Fisher Scientific).
Comparative genomics and phylogenetics
Characterised LITAF domain protein sequences from H.
sapiens were used as initial queries to identify putative
LITAF domain proteins from the genomes of the organisms
listed in (Additional file 1: Figure S1). Where no homologue
was identified, secondary searches were carried out using
identified sequences from more closely related taxa. Gen-
ome searches were carried out using the basic local align-
ment search tool (BLAST) against publicly available
genome databases accessible via NCBI [61] with exception
of those listed below; Plasmodium falciparum (PlasmoDB,
[62]); Toxoplasma gondii (ToxoDB, [63]); Naegleria gruberi,
Guillardia theta, Emiliania huxleyi, Bigelowiella natans,
Phaeodactylum tricornutum, Phytophthora sojae, Psuedo
nitzschia multiseries, Populus trichocarpa, Selaginella moel-
lendorffii, and Chlamydomonas reinhardtii (Joint Genome
Initiative, US Department of Energy [64]); Bodo saltans
(GeneDB [65]); Leishmania major, Trypanosoma cruzi, and
Trypanosoma brucei (TriTrypDB [66]); and Giardia lam-
blia (GiardiaDB [67]). All identified LITAF domain se-
quences were verified by reciprocal BLAST against the
non-redundant protein database (NCBI). For phylogenetic
reconstruction, protein sequences were aligned using
MAFFT via jalview [68, 69] and edited manually to remove
gaps and poorly conserved regions. Phylogenies were re-
constructed using Bayesian (MrBayes) and bootstrapped
maximum likelihood (RaxML, PhyML) approaches. PhyML
was run through the South of France Bioinformatics Plat-
form web server [70]. RaxML and MrBayes were run
through the Cyberinfrastructure for Phylogenetic Research
(CIPRES) Science Gateway web server [71]. MrBayes ver-
sion 3.2.2 analyses were run using a mixed model for 1 ×
106 generations, with convergence verified by standard de-
viation of split frequencies < 0.05. All trees before plateau
were removed as burn-in. The appropriate evolutionary
model was assigned using protest v2.4 [72]. Domain predic-
tion was carried out via the NCBI conserved domain
database (CDD), HMMScan (HMMER, Janelia) [73] and
InterProScan [74].
Immunofluorescence microscopy
For general immunofluorescence microscopy, cells were
plated on glass coverslips, fixed in 4% paraformaldehyde
and permeabilised with 0.1% TritonX-100 in phosphate
buffered saline (PBS) at pH 7.4. Bovine serum albumin
(BSA; 1%) in PBS was used to block fixed cells before in-
cubation with primary antibodies followed by AlexaFluor-
conjugated secondary antibodies. Cover slips were
mounted onto glass slides using ProLong Gold Antifade
Mountant with DAPI (Thermo Fisher Scientific). Wide-
field fluorescent images were obtained using a Zeiss Axioi-
mager Z2 Upright Wide-field microscope (Carl Zeiss),
and confocal images were acquired using Zeiss LSM710
and LSM880 confocal microscopes (Carl Zeiss). Imaging
data were analysed using Zeiss ZEN software (Carl Zeiss)
and Volocity (PerkinElmer).
Membrane fractionation and TX114 extraction
To isolate cellular membranes, HeLa cells were washed
with cold 10 mM Tris pH 7.4 before scraping into a small
volume of 10 mM Tris pH 7.4, 10 mM NaCl and 1.5 mM
MgCl2. The cells were then lysed by gently passing
through a 25G needle multiple times before centrifugation
at 1330 g for 10 minutes. The resulting supernatant was
then sonicated briefly on ice before further centrifugation
at 280,000 g for 45 minutes to obtain a membrane fraction
(pellet) and cytosolic supernatant. The membranes were
resuspended in an equal volume of buffer to the super-
natant before proceeding to SDS-PAGE and western blot-
ting. For the LITAF cysteine mutants, the membrane
pellets were additionally incubated with 10 mM Tris
pH 7.4, 10 mM NaCl, 1.5 mM MgCl2 and 1% TX100, and
complete protease inhibitor (Roche) to extract soluble
membrane proteins before a second centrifugation at
280,000 g for 45 minutes. The soluble supernatant was
transferred to a new tube and the insoluble pellet was re-
suspended with an equal volume of 10 mM Tris pH 7.4,
10 mM NaCl and 1.5 mM MgCl2 containing protease in-
hibitors before proceeding to SDS-PAGE and western
blotting. Phase partitioning of endogenous LITAF and
marker protein from HeLa cell membranes with Triton
X114 (Sigma-Aldrich) was performed as previously de-
scribed [75], with equal proportions of the detergent and
aqueous phases being analysed by western blotting.
Determination of LITAF membrane topology
HeLa cells stably expressing HA-LITAF-myc were gener-
ated using the pLXIN retroviral system (Clontech) as
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previously described [76], and a single transduced clone se-
lected for further study to ensure consistency across experi-
ments. Cells were seeded onto glass cover slips and left to
settle overnight. The following steps until fixation with para-
formaldehyde were performed on ice at 4 °C. The cells were
first washed twice with ice-cold KHM buffer (20 mM
HEPES pH 7.4, 110 mM potassium acetate, 2 mM MgCl2).
Digitonin (20 μM; Sigma-Aldrich) was then used to perme-
abilise the plasma membrane by incubating for 3 minutes
on ice before washing three times with ice-cold KHM buf-
fer. Free aldehydes where then quenched with 50 mM
NH4Cl in PBS for 5 minutes before twice washing with PBS.
Cells were next blocked with 1% BSA in PBS for 30 minutes
before incubation with primary antibodies for 1 hour on ice
at 4 °C. Following three further washes with PBS, the cells
were fixed with 4% paraformaldehyde at room temperature
for 15 minutes, washed with PBS and incubated with
AlexaFluor-conjugated secondary antibodies before mount-
ing on glass slides for immunofluorescence microscopy.
Digitonin (100 μM) was used to permeabilise both endoso-
mal membranes and plasma membranes, additionally ex-
posing epitopes on the luminal side of endocytic vesicles.
For cell-free expression of HA-LITAF-myc, a rabbit re-
ticulocyte lysate cell-free expression system was used in the
presence of canine microsomal membranes (Promega). The
signal peptide-containing protein, β-lactamase, served as a
control for membrane insertion and translocation into the
lumen of microsomes, and hence protection from added
protease digestion. The expressed proteins were incubated
with proteinase K (NEB) for 1 hour at 37 °C before separ-
ation by SDS-PAGE followed by western blotting.
Bacterial protein expression and purification
cDNAs corresponding to wild type LITAF, Δ114–139 and
N-helix were cloned into the pOPINS vector before expres-
sion of the resulting His6-SUMO-tagged protein constructs
in C43(DE3) BL21 E. coli. Bacterial lysates were prepared by
cell disruption of the bacterial pellet in lysis buffer (50 mM
HEPES pH 7.4, 300 mM NaCl, 3 mM 2-mercaptoethanol,
200 μM AEBSF) followed by centrifugation of insoluble ma-
terial at 100,000 g for 30 minutes. His6-SUMO-LITAF con-
structs were purified from lysates using Ni-NTA resin
(Qiagen) and the eluting imidazole removed using Centri-
pure P25 Zetadex gel filtration columns (Generon) and the
protein buffer-exchanged into 20 mM HEPES pH 7.4,
100 mM NaCl, 0.5 mM TCEP. The purified protein was
then incubated with ULP1 SUMO protease for 1 hour at
room temperature and the His6-SUMO tag removed by a
second incubation with Ni2+-NTA. The final purification
step consisted of size exclusion chromatography using a
Superdex 200 10/300 gel filtration column (GE Healthcare
Life Sciences). Protein samples were concentrated using
Vivaspin centrifugal concentrators (Sartorius, UK) and any
insoluble particles removed using Proteus clarification mini
spin columns (Generon). For NMR analysis, proteins were
expressed in C43(DE3) BL21 E. coli grown in minimal
media containing ammonium-15N chloride (Sigma-Aldrich)
and/or 13C-D-Glucose (Cambridge Isotopes) as previously
described [77]. For wild type LITAF constructs (containing
the predicted hydrophobic helical membrane anchor), de-
tergents were required at each step to maintain solubility.
For the experiments described in this study, 1% DDM (w/v)
or 1% FC12 were used for cell lysis and 0.04% DDM (w/v)
or 0.125% FC12 added to each subsequent buffer when
dealing with the full length wild type LITAF protein. For
GST-tagged proteins, cDNA encoding residues 1–77 of hu-
man LITAF and residues 596–944 of human NEDD4 were
cloned into pGEX-4 T1 expression vector (GE Healthcare
Life Sciences) for expression in C43(DE3) BL21 E. coli. Puri-
fication was performed using glutathione sepharose 4B ac-
cording to the manufacturer’s instructions (GE Healthcare
Life Sciences). For NMR analysis, purified GST-NEDD4
596–944 was buffer-exchanged into 20 mM HEPES pH 7.4,
100 mM NaCl and 0.5 mM TCEP by using a Superdex 75
10/300 gel filtration column (GE Healthcare Life Sciences).
GST pull-down assays
Cell lysates were prepared by scraping RPE cells into a
small volume of lysis buffer (20 mM HEPES pH 7.4;
150 mM NaCl; 1 mM EDTA; 0.5% Triton X-100 (v/v);
complete protease inhibitor (Roche)) and transferring into
a 1.5 mL microcentrifuge tube. The lysate was then sheared
by gently passing the solution back and forth through a 21-
G needle followed by a 25-G needle, before centrifugation
at 20,000 g for 30 min at 4 °C. The resulting supernatant
was first precleared by gentle agitation for an hour at 4 °C
with glutathione sepharose 4B beads (GE Healthcare Life
Sciences) before the addition of GST-LITAF 1–77 con-
structs at a concentration of 0.2 mg/mL. Following a fur-
ther incubation for 2 hours at 4 °C with gentle agitation,
glutathione sepharose 4B beads were added and incubated
for 1 hour more with gentle agitation at 4 °C. The beads
were washed twice with lysis buffer and once with PBS
before elution of the bound proteins by heating in SDS
sample buffer (6 M Urea, 1% SDS (w/v), 1 M 2-
mercaptoethanol and 150 mM Tris (pH 6.7)). Eluted pro-
teins were separated by SDS-PAGE and transferred to
nitrocellulose membranes for western blotting.
Cycloheximide chase
RPE cells stably expressing wild type HA-LITAF or HA-
LITAF V144M were seeded before incubation with 300 μg/
mL of cycloheximide (Sigma). Cells were lysed in RIPA buf-
fer at 0, 1, 2, 4, 8 and 24 hours after incubation with cyclo-
heximide before brief sonication and centrifugation at
20,000 g for 30 minutes at 4 °C. The supernatants were
transferred to new tubes and the protein concentration de-
termined using Precision Red reagent (Cytoskeleton, Inc.).
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Equal amounts of protein were separated by SDS-PAGE
before analysis by western blotting.
MicroPIXE
The unambiguous identity of the metals in the recombi-
nantly expressed LITAF proteins and their stoichiometry
was determined using microPIXE (microbeam Proton In-
duced X-ray Emission), an established technique for such
analyses [78]. The recombinant proteins were prepared as
described above before buffer exchange into 10 mM Tris
pH 7.4, 200 mM NaBr and 0.5 mM TCEP using a Super-
dex 75 GL size exclusion chromatography column (GE
Healthcare Life Sciences). DDM (0.04%) was also used to
maintain the solubility of wild type LITAF constructs for
the purpose of these experiments. Resulting protein con-
centrations, estimated by measuring the absorbance at
280 nm, were 1.7 mg/mL, 4.7 mg/mL and 1.7 mg/mL for
wild type LITAF, LITAF Δ114–139 and LITAF N-helix, re-
spectively. This pre-measurement buffer exchange was
also necessary to remove any traces of sulfur and chlorine.
For micro-PIXE measurements of proteins, sulfur acts as
an internal standard, and because of the proximity of the
X-ray emission energies of sulfur and chlorine to one an-
other, strong chloride fluorescence can affect the accuracy
with which the sulfur peak can be quantified [78]. The
measurements were carried out at the Ion Beam Centre,
University of Surrey, UK [79]. A 2.5-MeV proton beam of
3 μm in diameter was used to induce characteristic X-ray
emission from dried liquid protein droplets (volume per
droplet = 0.1 μL) under vacuum. The X-rays were detected
in a solid state lithium drifted silicon detector with high
energy resolution. By scanning the proton beam in x and y
over the droplet, spatial maps were obtained of all ele-
ments heavier than magnesium present in the sample.
Quantitative information was obtained by collecting 3- or
4-point spectra from each droplet. These spectra were an-
alyzed with GUPIX [80] within DAN32 [81] to extract the
relative amount of each element of interest in the sample.
NMR experiments and analysis
15N- and 13C-labelled proteins were prepared in 20 mM
HEPES pH 7.4, 100 mM NaCl, 0.5 mM Tris(2-carbox-
yethyl)phosphine hydrochloride (TCEP) at typical con-
centrations of between 60 and 250 μM. All experiments
were collected at 298 K on Bruker Avance III 600 MHz
and Avance 2+ 700 MHz spectrometers equipped with
cryogenic triple resonance TCI probes. Data were proc-
essed using the software packages Topspin 3.2 (Bruker)
and both Multi-Dimensional Decomposition [82] and
Compressed Sensing [83] for data collected by Non Uni-
form Sampling. All NMR data were analyzed using
SPARKY 3 (T. D. Goddard and D. G. Kneller, University
of California, San Francisco).
1D proton transverse relaxation (T2) experiments were
used to estimate the molecular weight of the LITAF do-
main. For a globular protein, its transverse relaxation is
governed by its molecular weight by the following rela-
tionship: MW× 0.5 ≈ 1/5 × T2, where T2 is in seconds and
MW is in kDa. Standard 1D proton transverse relaxation
experiments were collected with different delays (1 and 2),
with observed peak intensities reduced after an increased
delay. T2 can therefore be estimated using the following
equation: T2 = 2(Δ1–Δ2)/ln(I1/I2), where I is the peak
intensity and Δ is the relaxation delay.
Backbone chemical shift assignments were completed
using HNCO, HNCACO, HNCA, HNCACB and CBCA-
CONH. The assignment of proline residues was aided by
13C observed CON experiments complimented with
HCBCANCO, HCBCACON, HNCANNH and HNCO-
CANNH experiments. Side chain HA and HB were
assigned using an HBHACONH experiment. Through
space contacts were established by 15N and 13C HSQC
NOESY experiments.
Secondary structure predictions were made using N,
HN, CA, CB and HA chemical shifts and TALOS+ [29].
Assigned BEST-TROSY (band selective excitation short
transients transverse relaxation optimized spectroscopy)
were used to make weighted chemical shift maps on mu-
tation and head group or NEDD4 WW domain interac-
tions using the equation ((Δ1H)2 + (Δ15N/5)2)0.5, where
the Δ denotes the difference in parts per million of the
chemical shift between the assigned apo peak and its near-
est neighbour in the mixed sample spectra.
In the head group experiments, PG, PC, PS, PE and
IP6 head groups were sourced from Sigma-Aldrich and
incubated with LITAF (60 μM concentration) at molar
ratios of 1:1000 (PG, PC, PE) and 1:500 (PS, IP6). The
pH of each LITAF/head group mixture was checked and
found to be the same as the sample used to generate the
control spectra.
LITAF structure modelling
NMR assignment information was submitted to the CS
Rosetta webserver for de novo structure calculations [31,
84], which did not return a convergence of structures,
suggesting a low confidence in the prediction. Given the
established metal coordination of the LITAF constructs
and NMR restraints, a zinc-bound structure model
methodology was then followed using CS-Rosetta frag-
ment files with the abinitio.metalrelax protocol of the
Rosetta package [32]. The jump restraint file was edited
so that the zinc atom coordinated cysteine residues C96,
C99, C148 and C151 (full length residue numbers). Run-
ning the scripts for both the LITAF Δ114–139 and wild
type LITAF domains returned 5000 structural models
for each construct (also referred to as decoys) of im-
proved confidence. These decoys were clustered with a
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5 Å cutoff using Calibur [33] and scored for similarity to
the centre of each cluster using the score_jd2 script that
is part of the Rosetta package. The structures shown in
Figs. 6 and 8 were representative of the lowest energy
structures of the largest cluster in each calculation
round.
Additional files
Additional file 1: Figure S1. LITAF domains are conserved across the
eukaryotes. Coulson plot showing the distribution of LITAF domain-containing
proteins across the eukaryotes. Filled circles indicate the presence of a gene
encoding a protein with an identifiable LITAF domain. Unfilled circles indicate
taxa where no LITAF domain proteins could be identified. Numbers within
circles indicate the number of distinct genes encoding proteins bearing LITAF
domains. (PDF 77 kb)
Additional file 2: Figure S2. Phylogenetic reconstruction of the evolution
of LITAF domain proteins within the chordates. The best Bayesian topology is
shown (MrBayes) with branch support for key nodes indicated according to
the key. (PDF 33 kb)
Additional file 3: Figure S3. Predicted domain organisation of
representative LITAF domain proteins from across the eukaryotes. (PDF 36 kb)
Additional file 4: Figure S4. Sequence of human LITAF and alignment of
representative eukaryote LITAF domains. (a) Amino acid sequence of human
LITAF. Residues comprising the C-terminal LITAF domain are outlined in red.
The two PPSY motifs that are predicted to interact with WW domains, and the
PSAP motif that can associate with the UEV domain of TSG101 that are present
in the N-terminal proline-rich region are outlined by blue and green boxes,
respectively. (b) LITAF domain alignment constructed from representative taxa
encompassing the diversity of eukaryotes. Residues are numbered according
to the human LITAF sequence and coloured according to the Clustalx scheme
as implemented in the Jalview program to highlight conserved amino acid
properties. Shading indicates the degree of conservation. The conserved
cysteine residues are coloured red and denoted with asterisks. (c) Helical wheel
alignment of residues 113–134 of LITAF, predicted to form a helix by Jpred4
[86], to illustrate the predicted clustering of hydrophobic residues on one face
of the helix, compatible with an amphipathic helix. (d) Helical wheel alignment
of residues 113–134 of LITAF, with the hydrophobic residues on one face of
the helix substituted with asparagine (N), as found in the soluble LITAF N-helix
construct. (PDF 1131 kb)
Additional file 5: Figure S5. Intracellular localisation of LITAF.
Colocalisation immunofluorescence studies of wild type (WT) LITAF
constructs stably expressed in retinal epithelial cells (RPE) by confocal
microscopy. Epitope-tagged LITAF WT targeted to punctate structures
with partial colocalisation with markers of early endosomes (EEA1, Rab5),
late endosomes/lysosomes (CD63, LAMP1) and with the retromer
component, VPS26. Minimal colocalisation of HA-LITAF WT with the trans
Golgi network marker (TGN46) or plasma membrane marker, wheat germ
agglutinin, was observed. Scale bar denotes 10 μm. (PDF 3672 kb)
Additional file 6: Figure S6. (a) Schematic diagram illustrating the
position of the conserved cysteine residues mutated to alanine in the N-term
AxxA and C-term AxxA HA-LITAF constructs. (b) HA-LITAF constructs were
transiently expressed in HeLa cells and visualised by immunofluorescence
confocal microscopy. In contrast to the wild type LITAF, which targeted
multiple punctate structures consistent with endosomes (HA-LITAF WT, left
panel), the LITAF constructs in which the N-terminal or C-terminal conserved
cysteine pairs were mutated to alanine (HA-LITAF N-term AxxA and HA-LITAF
C-term AxxA) appeared in large puncta, consistent with them being proteins
prone to aggregation. Nuclei were stained with DAPI. Scale bars denote
10 μm. (c) Membrane fractionation from HeLa cells transiently expressing
HA-LITAF constructs. A soluble fraction (Soluble) was obtained following high
speed centrifugation. The resulting membrane pellet was further incubated
with 1% TX100 in order to extract soluble membrane proteins (TX100) from
insoluble material (Pellet). Calnexin and tubulin were used for control purposes
as examples of integral membrane and soluble proteins, respectively. While
HA-LITAF WT was found in the TX100 solubilised membrane fraction similarly
to calnexin, HA-LITAF construct harbouring mutations in either the N-terminal
or C-terminal conserved cysteine pairs within the LITAF domain were found
predominantly in the TX100 insoluble pellet (P), consistent with protein
aggregation. Note that longer exposure times were required for the cysteine
mutant samples as the expression level of these mutated proteins was
consistently lower compared to wild type. (PDF 246 kb)
Additional file 7: Figure S7. (a) Representative traces of recombinantly-
expressed LITAF wild type (WT; green), LITAF N-helix (red) and LITAF Δ114–
139 (blue) subjected to size exclusion chromatography (SEC) using a Superdex
200 10/300 GL column (GE Healthcare Life Sciences). The broad peak on the
SEC column corresponding to LITAF WT indicated the presence of higher
order oligomers. (b) Fractions from the size exclusion chromatography of
LITAF WT (arrows labelled 1–10 in (a)) were separated by SDS-PAGE and
visualised with InstantBlue (Expedeon). A protein band corresponding to LITAF
WT was present in fractions 2–10. (c) Western blot of fractions 2–10 from the
size exclusion chromatography of LITAF WT separated by native gel
electrophoresis before transfer to a nitrocellulose membrane and
immunoblotted for LITAF. Note that LITAF WT exists as larger molecular
weight species in the earlier fractions compared to the later fractions,
consistent with the size exclusion chromatography trace seen in (a), and
consistent with the formation of higher order oligomers. (PDF 1825 kb)
Additional file 8: Figure S8. Comparison of 15N-BEST-TROSY spectra of
the LITAF Δ114–139 and N-Helix constructs. The N-helix construct can be
assumed to adopt a wild type (WT)-like fold as its sequence only differs in
mutations that remove the amphipathic nature of the helix, whilst maintaining
a helical secondary structure. The comparison of amide chemical shifts of
LITAF N-helix with the truncated Δ114–139 construct reveals very few changes
in the chemical environment that the structured LITAF domain is exposed to,
with just a small number of shifts seen in residues that are close to the
predicted helix/truncation point (labelled residues). This strongly suggests that,
while the truncated LITAF Δ114–139 construct does not contain the predicted
helix of the WT protein, the data gleaned from this construct is comparable to
a pseudo-WT construct. (PDF 632 kb)
Additional file 9: Figure S9. (a) The secondary structure boundaries of
the LITAF Δ114–139 construct as defined by the TALOS+ analysis of the
backbone assignment. Areas of β-sheet are shown with blue arrows. (b) The
heteronuclear NOE (hetNOE) analysis of the LITAF Δ114–139 construct. When
the HetNOE values are positive and close to 1, residues have a reduced
motion on the picosecond time scale and are likely to be part of defined
secondary structure motifs. The unstructured N-terminus has negative peaks
suggesting increased flexibility on the picosecond time scale, with the
exception of a small region between residues Ser22 and Tyr33. (PDF 332 kb)
Additional file 10: Figure S10. 15N-BEST-TROSY spectra of LITAF Δ114–
139 wild type (WT; black) overlaid with phosphoethanolamine (PE, pink),
phosphoglycerol (PG, yellow), phosphocholine (PC, blue), phosphoserine
(PS, orange), and inositolhexakisphosphate (IP6, red), respectively. These
data show that, while LITAF Δ114–139 WT does not interact with PG, PC,
PS or IP6, discrete interactions between specific residues located in the
C-terminal LITAF domain and PE head groups were observed (top right
panel). (PDF 378 kb)
Additional file 11: Figure S11. (a) The weighted chemical shift
perturbations that occur in the LITAF Δ114–139 wild type construct in
the presence of phosphoethanolamine (PE) are shown. In summary, PE
interacts with specific residues in the C-terminal LITAF domain. (b) The
weighted chemical shift perturbations seen in the LITAF Δ114–139
construct harbouring the CMT1C-associated pathogenic mutation,
V144M, compared to wild type. This mutation not only causes chemical
shifts in the local vicinity of the substitution site (the mutated residue is
shown in grey) but also affects residues in the other β-sheet region on
the N-terminal side of the LITAF domain. (PDF 266 kb)
Additional file 12: Figure S12. (a) The position of disease-associated
residues mutated in CMT1C are shown in magenta on the structural model of
the human LITAF domain. Note that the residues mutated in Charcot-Marie-
Tooth disease are in and around the region of the predicted hydrophobic hel-
ical membrane anchor. Valine 144 (mutated to Methionine in CMT1C and
present in the LITAF Δ114–139 construct) is circled. (b) Flag-tagged LITAF WT
and LITAF V144M were transiently expressed in HeLa cells and visualised by
confocal immunofluorescence microscopy. Both constructs targeted to
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punctate structures consistent with endosomes. Nuclei were visualised with
DAPI. Scale bar denotes 10 μm. (c) Western blot from membrane fractionation
experiments from HeLa cells transiently expressing Flag-tagged LITAF WT or
Flag-tagged LITAF V144M. Both constructs are found in the membrane pellets
(P), as opposed to the soluble fraction (S). Calnexin and tubulin were used as
integral membrane and soluble protein controls, respectively. (PDF 12512 kb)
Additional file 13: Figure S13. 15N-BEST-TROSY spectra of the LITAF
Δ114–139 wild type (WT; dark blue, top panels) and LITAF Δ114–139
V144M (red, bottom panels) constructs overlaid with 1:250 and 1:1000 PE
mixtures, respectively. These data show that whilst both the WT and
V144M constructs interact with PE head groups, the V144M construct
becomes insoluble at the higher PE concentrations. (PDF 673 kb)
Additional file 14: Individual data values from three biological replicates,
each consisting of 10–13 technical replicates, used to quantitate the degree
of colocalisation between HA-LITAF constructs and wheat germ agglutinin
as illustrated in Fig. 7d. (XLSX 11 kb)
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